Tsutomu Yamazaki

Dr. Tsutomu Yamazaki

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2023 in Nature
Verified
Journal Article
Open access
PDF file
TTTadashi Takeuchi
Tadashi Takeuchi
TKTetsuya Kubota
Tetsuya Kubota
YNYumiko Nakanishi
Yumiko Nakanishi
HTHiroshi Tsugawa
Hiroshi Tsugawa
WSWataru Suda
Wataru Suda
HOHiroshi Ohno
Hiroshi Ohno
Insulin resistance is the primary pathophysiology underlying metabolic syndrome and type 2 diabetes1,2. Previous metagenomic studies have described the characteristics of gut microbiota and their roles in metabolizing major nutrients in insulin resistance3–9. In particular, carbohydrate metabolism of commensals has been proposed to contribute up to 10% of the host’s overall energy extraction10, thereby playing a role in the pathogenesis of obesity and prediabetes3,4,6. Nevertheless, the underlying mechanism remains unclear. Here we investigate this relationship using a comprehensive multi-omics strategy in humans. We combine unbiased faecal metabolomics with metagenomics, host metabolomics and transcriptomics data to profile the involvement of the microbiome in insulin resistance. These data reveal that faecal carbohydrates, particularly host-accessible monosaccharides, are increased in individuals with insulin resistance and are associated with microbial carbohydrate metabolisms and host inflammatory cytokines. We identify gut bacteria associated with insulin resistance and insulin sensitivity that show a distinct pattern of carbohydrate metabolism, and demonstrate that insulin-sensitivity-associated bacteria ameliorate host phenotypes of insulin resistance in a mouse model. Our study, which provides a comprehensive view of the host–microorganism relationships in insulin resistance, reveals the impact of carbohydrate metabolism by microbiota, suggesting a potential therapeutic target for ameliorating insulin resistance.

10 April 2020 in Circulation Reports
Verified
Journal Article
Open access
PDF file
RTRika Takeyasu
Rika Takeyasu
YTYuichi Tamura
Yuichi Tamura
KAKohtaro Abe
Kohtaro Abe
AGAyumi Goda
Ayumi Goda
TSToru Satoh
Toru Satoh
KTKoichiro Tatsumi
Koichiro Tatsumi
Background:The emPHasis-10 questionnaire is a disease-specific patient-reported outcome assessment of quality of life (QOL) in pulmonary hypertension (PH). The aim of this study was to psychometrically validate a linguistically validated Japanese version of the emPHasis-10.Methods and Results:Japanese patients with PH (age ≥18 years) and no change in functional status, or initiation or change in PH-specific treatment during the past 3 months were recruited from 5 institutions from August 2018 to July 2019. A set of questionnaires was administered twice. The validity and reliability of the emPHasis-10 were assessed using the data of 76 patients. On concurrent validity analysis, a moderate-to-strong correlation was seen with the total score of all 5 external criteria (the Minnesota Living with Heart Failure modified for PH [MLHFQ-PH], Hospital Anxiety and Depression Scale, Dyspnea-12 questionnaire, European Quality of Life-5 Dimensions questionnaire [EQ-5D], and 6-min walk test), with a notably strong correlation with the MLHFQ-PH (0.77) and EQ-5D (–0.64). On known-group validity, a linear increasing trend of the emPHasis-10 score was observed across 4 World Health Organization functional status groups (Jonckheere-Terpstra test, 1-sided, P<0.001). Intraclass correlation coefficient for test-retest reliability was 0.86, and the Cronbach’s α for internal consistency was 0.89.Conclusions:The Japanese emPHasis-10 questionnaire is psychometrically valid to evaluate QOL in Japanese PH patients in a clinical setting.

23 August 2016 in ECS Journal of Solid State Science and Technology
Verified
Journal Article
Open access
PDF file
TDToshiro K. Doi
Toshiro K. Doi
KSKiyoshi Seshimo
Kiyoshi Seshimo
TYTsutomu Yamazaki
Tsutomu Yamazaki
MOMasanori Ohtsubo
Masanori Ohtsubo
DIDaizo Ichikawa
Daizo Ichikawa
HAHideo Aida
Hideo Aida
An innovative dilatancy polishing pad of which characteristics are controlled with processing conditions is proposed to establish high-efficiency, high-quality polishing of hard-to-machine materials for next-generation high-power devices. To make the best use of the property of the dilatancy pad, a highly durable polishing machine which enables high-pressure, high-speed, and immersed polishing was developed. Dilatancy properties were evaluated for various viscoelastic materials to select appropriate materials for a pad. The selected viscoelastic material was mixed with a special filler and abrasive particles, and integrated into a conventional polishing pad to form a dilatancy pad. Application of the dilatancy pad to polishing of SiC realized a smart polishing which achieves both high efficiency and high quality in any processing conditions. In addition, it was demonstrated that the processing conditions could be selected for the purpose of each polishing step, i.e. mid- to high-speed conditions for high-efficiency polishing and low-speed condition for high-quality finishing. A newly developed highly durable polishing machine is capable of achieving wide range of processing conditions. To avoid overheating under high load conditions, the machine can polish a work piece in slurry fluid. The material removal rate using the dilatancy pad showed superlinear dependence on the rotation speed, which outperforms the conventional polishing following the Preston's law. This innovative process can significantly reduce the polishing time of hard-to-machine materials for next-generation semiconductor devices.

3 December 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
MIMari Igarashi
Mari Igarashi
Ryuichi OhtaRyuichi Ohta
Ryuichi Ohta
YKYasuo Kurita
Yasuo Kurita
ANAkinori Nakata
Akinori Nakata
TYTsutomu Yamazaki
Tsutomu Yamazaki
HGHarumi Gomi
Harumi Gomi
Nurse practitioners (NPs) provide medical care equivalent to that of physicians and facilitate access to healthcare. Although Japan’s first NP graduated in 2010, how Japanese expert NPs work effectively in clinical contexts is yet to be investigated. We aimed to identify the competencies that make expert NPs in Japan effective. Twelve Japanese expert NPs were purposely selected. The average age of the participants was 44.8 years, average NP experience was 7.5 years, and eight participants were women. Semi-structured interviews were conducted online from March to May 2021. Interviews were recorded, transcribed verbatim, and analyzed using thematic analysis. Thematic analysis revealed five themes: working in physicians’ contexts, interprofessional collaboration, involvement in nurses’ work, contribution to healthcare, and personal qualities for effective working. Japanese expert NPs can function effectively in clinical settings by flexibly and humbly collaborating with other medical professionals who have autonomous positions. They can improve the quality of healthcare by proposing practical solutions to problems faced by patients and medical organizations. These explored competencies can be applied to other aging and more complex societal contexts, and in updating the required competencies of Japanese NPs.

21 November 2022 in Nursing Reports
Verified
Journal Article
Open access
PDF file
MIMari Igarashi
Mari Igarashi
Ryuichi OhtaRyuichi Ohta
Ryuichi Ohta
ANAkinori Nakata
Akinori Nakata
YKYasuo Kurita
Yasuo Kurita
YMYuta Mitobe
Yuta Mitobe
HGHarumi Gomi
Harumi Gomi
Background: Nurse practitioners (NPs) are known as effective healthcare providers worldwide. In Japan, nurse practitioner adoption is considered to be in a shaky period. Although nurse practitioners were introduced approximately 10 years ago at the initiative of educational institutions in Japan, the full extent of this trend is not known. Therefore, we have clarified the whole picture of nurse practitioners from two directions: the perception of nurse practitioners in Japan and the perception of physicians who work with nurse practitioners. This will inform discussions regarding the recruitment of nurse practitioners at the national level in Japan. Methods: From 18 June to 24 July 2021, we administered a nationwide cross-sectional survey of NPs and physicians working in the same clinical settings as NPs in Japan. The domains of the survey included “scope and content of work”, “perceptions of NPs’ clinical practice”, and “individual clinical practice characteristics”. The survey was distributed and collected digitally. Results: The total number of respondents to the survey was 281, including 169 NPs and 112 physicians; the percentage of NPs who responded was 50.5%. The number of valid responses was 164 NPs and 111 physicians, for a total of 275 respondents. Approximately 60% of NPs are concentrated in Tokyo, the capital of Japan, and the three prefectures adjacent to Tokyo. They also worked fewer hours per week, cared for fewer patients per day, and earned less money than physicians. More physicians than NPs indicated that “more NPs would improve the quality of care”. A total of 90.1% of physicians and 82.3% of NPs agreed that “Nurse practitioners should practice to the full extent of their education and training,” and 73.9% of physicians and 81.7% of NPs agreed that “Nurse practitioners’ scope of practice should be uniformly defined at a national level”. Conclusions: This study clarified the present working conditions of NPs from NPs’ and physicians’ perspectives in Japanese contexts. Japanese NPs may be able to work effectively in collaboration with physicians. Therefore, the implementation of NPs in Japanese medical conditions should be discussed further for better healthcare.

21 January 2025 in Infection Prevention in Practice
Verified
Journal Article
Open access
TNTaikan Nanao
Taikan Nanao
KIKoichi Benjamin Ishikawa
Koichi Benjamin Ishikawa
SIShunya Ikeda
Shunya Ikeda
TYTsutomu Yamazaki
Tsutomu Yamazaki
Ventilator-associated pneumonia (VAP) has a considerable impact on both clinical outcomes and healthcare costs. This study compared 40 patients having VAP with 40 matched controls from a Japanese ICU dataset. Patients with VAP experienced significantly longer ICU and hospital stays, fewer ventilator-free days, and a higher incidence of tracheostomies. VAP cases also required more broad-spectrum antimicrobials, leading to an additional cost of approximately USD 24,410 per case. These results highlight the importance of implementing effective infection control strategies to mitigate VAP's clinical and economic consequences.